Ascendis Pharma A/S EV - Enterprise Value 2011-2026 | ASND

Annual EV - Enterprise Value Ascendis Pharma A/S

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
726 M	579 M	382 M	7.12 B	8 B	5.95 B	2.34 B	1.18 B	394 M	344 M	349 M	20.4 M	23.8 M	22.6 M

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
8 B	20.4 M	1.96 B

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Adaptimmune Therapeutics plc ADAP	2.15 B	-	-15.15 %	$ 60.3 M	Britain
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Aptorum Group Limited APM	9.45 M	$ 0.83	2.17 %	$ 4.53 M	China
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
BioNTech SE BNTX	-6.64 B	$ 110.14	3.3 %	$ 27.2 B	Germany
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Adagene ADAG	395 M	$ 2.6	-1.12 %	$ 146 M	China
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
AlloVir ALVR	-64.1 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.51	-0.52 %	$ 8.45 B	Australia
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 4.21	1.2 %	$ 9.16 B	Israel
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	725 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	486 M	$ 1.49	7.19 %	$ 279 M	USA
Aptose Biosciences APTO	10.8 M	-	-45.71 %	$ 1.2 M	Canada
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	5.65 B	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	38.2 M	-	17.91 %	$ 11.1 M	USA
Burford Capital Limited BUR	3.22 B	$ 8.96	0.45 %	$ 1.41 B	Britain
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Athira Pharma ATHA	-18.3 M	-	-	$ 269 M	USA
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	1.11 B	$ 1.46	2.46 %	$ 373 M	Britain
Amneal Pharmaceuticals AMRX	1.72 B	$ 14.49	-0.24 %	$ 4.48 B	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	-15.2 M	$ 2.35	-1.81 %	$ 14.8 M	USA
AstraZeneca PLC AZN	57.7 B	-	-	$ 96.9 B	Britain
Brickell Biotech BBI	515 K	-	-5.38 %	$ 6.06 M	USA